October 17, 2019 will mark the expansion of the cannabis regulations in Canada allowing for concentrates, vapes and an expanded range of formulated medical products. EnCann expects to receive its Standard Processor License in time for the launch of this new market and is poised to help cultivators and product manufacturers to take advantage of the coming shift in customer demand. 

Every aspect of EnCann’s oil production is subject to Health Canada’s regulations and monitoring requiring quality testing in a controlled environment: a clean and secure pharmaceutical grade facility where all products are carefully tracked. 

EnCann’s extraction process is a proprietary, patent-pending system which will revolutionize the cannabis industry


By employing the newest technologies, EnCann is able to process cannabis and industrial hemp biomass at industrial scale, all while maintaining a top-quality product. The company is focused on becoming a premier service provider to Canadian hemp cultivators, cannabis cultivators and edibles and other specialty manufacturers.

As consumers become more educated, providing an expanded product range including capsules, topicals, unique oral release profiles and nanoemulsions will become key for Standard and Micro Cultivators to remain competitive and to maintain their profit margins. Through our white labelling services, EnCann will allow cultivators to provide an expanded product line.

At this time, we are looking for investors to help us to advance our vision of driving growth and fostering excellence in the cannabis industry. EnCann offers a unique opportunity to invest in a market which is seeing unprecedented growth, a privately held company focused on creating profit and in an established team of cannabis industry experts. 

For more information or investment inquiries, please email or call Darcy Dando, CFO, or see our Investors Presentation below:

Investor Presentation